Dipyrone-NSAID Hybrids as CB2 Inverse Agonists Endowed with Analgesic Properties

Vol 2, 2022 - 152409
Poster
Favorite this paper
How to cite this paper?
Abstract

Modulation of endocannabinoid system contributes to analgesia, highlighting its promising role on the suppression of neuropathic pain. Recently, arachidonylamides have been identified as cannabinoid receptor ligands, which suggests their potential role on the analgesic activity displayed by dipyrone. Compounds 6-11 were designed by molecular hybridization of non-steroidal anti-inflammatory drugs (2-4) with the major metabolites of dipyrone. All substances were obtained in good yields (50-80%) and presented good drug-like properties, such as aqueous solubility (10-70 μM), lipophilicity (log D7.4 ranging from 1-3), metabolic and chemical stability against pH (2 and 7.4). Compounds 6-11 showed medium to high permeability by PAMPA assay (GIT and BBB). The compounds presented inverse agonist activity for CB2 receptors in vitro (EC50 = 0.36 µM; Emax = 63%). Compound 11 was selected to demonstrate their analgesic activity in the formalin test and the results indicated activity in the inflammatory phase associated with an pain condition.

Share your ideas or questions with the authors!

Did you know that the greatest stimulus in scientific and cultural development is curiosity? Leave your questions or suggestions to the author!

Sign in to interact

Have a question or suggestion? Share your feedback with the authors!

Institutions
  • 1 Universidade Federal do Rio de Janeiro
Track
  • 2. Medicinal Chemistry of Synthetic Compounds
Keywords
Cannabinoid receptors
Pyrazolamides
Molecular Hybridization
Inverse agonist
Analgesics